# Progress Note 04 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marilyn Monroe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML002-SYN
- Date: 2026-08-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Joanna Whitlock, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Periodic adult preventive visit, with pregnancy planning. **S**

## History of present illness

Ms. Monroe is a 30-year-old actor who comes for her yearly preventive visit, nine weeks after her first visit for painful periods. Endometriosis with a left ovarian endometrioma was diagnosed by ultrasound at the gynecology consultation. On the continuous combined pill she has had no periods, only two days of light spotting, and her worst pelvic pain has fallen; she has used naproxen on only a few days. Pain with deep intercourse persists. The bladder infection last month cleared within two days of nitrofurantoin. She has had six sessions of cognitive behavioral therapy, sleeps better, and stopped diphenhydramine. She married this summer. She would like to try for a pregnancy in about a year and wants to know what to do before then. Her PHQ-9 today is 8. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 30 |
| Endometriosis | No periods on the continuous pill; less pain; deep pain with intercourse persists |
| Pregnancy plans | Would like to try in about a year |
| Mood | PHQ-9 8, from 12; item 9 scored 0; six therapy sessions |
| Sleep | Better; diphenhydramine stopped |

## Health risk assessment

Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Whitlock. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, better than in the spring |
| Psychosocial | Supported by her spouse and a close friend; working again without missed days this month |
| Substance use | AUDIT-C 2; no drugs; no opioid or sedative use |
| Tobacco | Never smoked |
| Physical activity | Walks 30 to 40 minutes most days; dance and movement classes for work |
| Nutrition | Regular meals; dairy or fortified foods daily |
| Sleep | Seven hours most nights, at regular times |
| Sexual and reproductive health | One male partner, her spouse; continuous combined pill; would like a pregnancy in about a year |
| Safety at home | Feels safe; no one hurts, threatens, or controls her; no firearm in the home |
| Road safety | Wears a seat belt |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight change, or night sweats |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | No hearing change or sore throat |
| Cardiovascular | Negative | No chest pain, palpitations, or leg swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No painful bowel movements since the periods stopped; no bleeding |
| Genitourinary | Positive | Deep pain with intercourse; no periods, two days of light spotting; no urinary symptoms since the infection cleared |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No changing moles or rash |
| Neurological | Negative | No headaches, migraine, or visual aura on the pill |
| Endocrine | Negative | No heat or cold intolerance |
| Psychiatric | Positive | Mood improving; PHQ-9 score 8; no thoughts of suicide or self-harm |

12 systems reviewed. **S**

## Current medications

- Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a month **S**
- Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free week **S**
- Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 110/70 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 56.6 kg; BMI 20.5 kg/m². All vital signs are synthetic.

PHQ-9: 8; AUDIT-C: 2. All results are synthetic.

## Change since baseline

- PHQ-9: 12 at baseline, 8 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 56.6 kg, BMI 20.5; blood pressure 110/70 |
| Neck | Thyroid normal; no lymph nodes |
| Cardiovascular | Regular rhythm; no murmur; no leg swelling |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft; mild left lower quadrant tenderness only on deep palpation |
| Pelvic | Normal external genitalia, vagina, and cervix. Primary HPV sample collected from the cervix. Bimanual examination deferred to the endometriosis review in four weeks at her request |
| Skin | No suspicious lesions |
| Psychiatric | Brighter, engaged; organized; no psychotic or manic features |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. Pregnancy-intention counseling: she would like to try in about a year, so she continues the continuous pill for pain control until then. Preconception steps started today: folic acid, review of immunity, and a plan to stop the pill at a preconception visit. Her MMR and varicella vaccinations are documented as two doses each, so no immunity tests are needed. **S**
   - Folic acid 0.4 mg daily, starting now.
   - Preconception visit before she stops the pill.
   - Influenza vaccine at the next visit, when the autumn supply is given.
   - Next preventive visit in one year.
2. **Endometriosis with a left ovarian endometrioma** (N80.102). Pain much improved on continuous suppression; deep pain with intercourse persists and will be assessed with a full pelvic examination at the review next month. No migraine with aura, blood pressure normal, non-smoker: the combined pill remains suitable. **S**
   - Continue the continuous combined pill.
   - Endometriosis review in four weeks.
3. **Major depressive disorder, single episode, moderate** (F32.1). PHQ-9 8, from 12: improving with cognitive behavioral therapy and better pain control, but not yet a 50% response. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in her phone. **S**
   - Continue therapy.
   - PHQ-9 and GAD-7 at the review in four weeks; discuss an antidepressant if the PHQ-9 has not fallen by half.

## Medication changes

- Started: Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 110/70 mmHg |
| Depression screening | Completed today | PHQ-9 score 8, from 12 at intake; item 9 scored 0; under treatment |
| Anxiety screening | Up to date | GAD-7 8 at intake; repeated at the endometriosis reviews |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 2 |
| Tobacco use | Completed today | Never smoked |
| Cervical cancer screening | Ordered | Last cytology four years ago was normal; primary HPV test collected today, every five years if negative |
| Contraception and pregnancy intention | Completed today | Would like a pregnancy in about a year; continuous combined pill continued for endometriosis pain and contraception until then; no condition that rules out estrogen |
| Folic acid | Completed today | 0.4 mg daily started for a woman planning a pregnancy |
| Intimate partner violence screening | Completed today | Negative; she feels safe |
| Chlamydia and gonorrhea screening | Up to date | Negative at the first visit as part of the pelvic pain evaluation; one partner |
| HIV and hepatitis C screening | Ordered | No result on record; once-in-a-lifetime tests drawn today with her agreement |
| Diabetes and cholesterol screening | Not indicated | Age 30 with a BMI of 20.5 and no risk factors |
| Influenza vaccine | Due | To be given at the next visit, when the autumn supply arrives |
| COVID-19 vaccine | Due | Discussed; she will decide at the next visit |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap five years ago; Tdap again in each pregnancy |
| Measles, mumps, rubella and varicella | Up to date | Two documented doses of each; immune before pregnancy |
| HPV vaccine | Up to date | Series completed in adolescence |

## Advance care planning

Voluntary advance care planning discussion of about 16 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here, and said that if she were ever too ill to decide, she would want her agent to know her wish to keep the chance of having children wherever possible. She chose not to record other treatment preferences today. To be revisited yearly. **S**

## Guideline basis

- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention

## Follow-up

- HPV, HIV, and hepatitis C results by phone. Endometriosis review in four weeks with a pelvic examination, PHQ-9, GAD-7, and the influenza vaccine. Next preventive visit in one year. **S**
- Next scheduled visit 2026-09-14: three-month review on continuous hormonal treatment: pain, bleeding, mood, and pain with intercourse. **S**
